Business Description

Description
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset -0.33
Debt-to-Equity -1.96
Debt-to-EBITDA -1.54
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.74
Distress
Grey
Safe
Beneish M-Score -4.87
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
9-Day RSI 43.02
14-Day RSI 44.96
6-1 Month Momentum % -83.2
12-1 Month Momentum % -87.65

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.49
Quick Ratio 0.38
Cash Ratio 0.16
Days Inventory 207.61
Days Sales Outstanding 32.07
Days Payable 190.72

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -9417.01

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % -61.4
Operating Margin % -546.48
Net Margin % -425.59
FCF Margin % -414.58
ROA % -45.52
ROIC % -64.26
ROC (Joel Greenblatt) % -81.27
ROCE % -72.61

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.01
EV-to-EBIT -1.13
EV-to-EBITDA -1.35
EV-to-Revenue 4.46
EV-to-FCF -1.08
Earnings Yield (Greenblatt) % -88.5
FCF Yield % -32681.82

Financials (Next Earnings Date:2024-05-15 Est.)

GLSHQ's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:GLSHQ

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Gelesis Holdings Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 12.14
EPS (TTM) ($) -0.7
Beta 0
Volatility % 256.21
14-Day RSI 44.96
14-Day ATR ($) 0.00002
20-Day SMA ($) 0.0021
12-1 Month Momentum % -87.65
52-Week Range ($) 0.0003 - 0.06805
Shares Outstanding (Mil) 73.34

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gelesis Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Gelesis Holdings Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Gelesis Holdings Inc Frequently Asked Questions

What is Gelesis Holdings Inc(GLSHQ)'s stock price today?
The current price of GLSHQ is $0.00. The 52 week high of GLSHQ is $0.07 and 52 week low is $0.00.
When is next earnings date of Gelesis Holdings Inc(GLSHQ)?
The next earnings date of Gelesis Holdings Inc(GLSHQ) is 2024-05-15 Est..
Does Gelesis Holdings Inc(GLSHQ) pay dividends? If so, how much?
Gelesis Holdings Inc(GLSHQ) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1